Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 2
  • 4
  • 4

Found 4 Alcohol Use Disorder trials

A listing of Alcohol Use Disorder medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 General Screening Protocol for Affected and Unaffected Participants in Studies of Alcohol Use Disorder.

General Screening Protocol for Affected and Unaffected Participants in Studies of Alcohol Use Disorder.

18-75 years
Healthy Volunteer
All genders
The goal is to conduct a screening procedure to be used in evaluating individuals either with or without an alcohol use disorder (AUD) to determine whether it is safe and appropriate for them to participate in a clinical trial, imaging study, genetic study, or other research protocol that matches their …
 Testing the Reward-Drinker Hypothesis of Naltrexone Using an Extended-Release Formulation

Testing the Reward-Drinker Hypothesis of Naltrexone Using an Extended-Release Formulation

18-65 years
All genders
Phase 4
This study is being conducted to compare the effects of a medication (extended-release naltrexone or XR-NTX) or placebo (an inactive substance) together with brief counseling on reducing or stopping drinking.   XR-NTX is approved by the U.S. Food and Drug Administration (FDA) for treating alcohol dependence. Its use is experimental …
 Imaging inflammation in individuals with Alcohol Use Disorder: an [18F]NOS study

Imaging inflammation in individuals with Alcohol Use Disorder: an [18F]NOS study

18-65 years
Healthy Volunteer
All genders
This is a research study for people ages 18-65 to learn more about how regular alcohol use affects inflammation in the brain and other organs. We will study this using a Positron Emission Tomography (PET/CT) scan using a radioactive imaging drug called [18F]NOS. [18F]NOS is an experimental radioactive molecule used …

A Randomized Double-blind Placebo-Controlled Study of Ibudilast for Treating Alcohol Use Disorder

18-99 years
All genders
Phase 2
Interventional
The goal of this is to evaluate the safety and effectiveness of the drug Ibudilast compared to placebo (an inactive pill) in reducing the number of drinking days and the amount of alcohol consumed by people who want to stop or reduce their drinking. Study duration 11 weeks and includes …